- Home
- SNY vs ADI Comparison
SNY vs ADI Comparison
Compare SNY & ADI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- ADI
- Stock Information
- Founded
- SNY 1994
- ADI 1965
- Country
- SNY France
- ADI United States
- Employees
- SNY N/A
- ADI N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- ADI Semiconductors
- Sector
- SNY Health Care
- ADI Technology
- Exchange
- SNY Nasdaq
- ADI Nasdaq
- Market Cap
- SNY 116.5B
- ADI 116.5B
- IPO Year
- SNY N/A
- ADI 1972
- Fundamental
- Price
- SNY $48.70
- ADI $245.68
- Analyst Decision
- SNY Buy
- ADI Buy
- Analyst Count
- SNY 2
- ADI 20
- Target Price
- SNY $62.50
- ADI $243.58
- AVG Volume (30 Days)
- SNY 2.1M
- ADI 3.4M
- Earning Date
- SNY 07-24-2025
- ADI 08-20-2025
- Dividend Yield
- SNY 3.31%
- ADI 1.61%
- EPS Growth
- SNY 39.56
- ADI N/A
- EPS
- SNY 5.45
- ADI 3.68
- Revenue
- SNY $48,817,552,946.00
- ADI $9,818,656,000.00
- Revenue This Year
- SNY $3.39
- ADI $13.86
- Revenue Next Year
- SNY $7.05
- ADI $10.86
- P/E Ratio
- SNY $17.56
- ADI $66.76
- Revenue Growth
- SNY N/A
- ADI N/A
- 52 Week Low
- SNY $45.80
- ADI $158.65
- 52 Week High
- SNY $60.12
- ADI $247.10
- Technical
- Relative Strength Index (RSI)
- SNY 43.32
- ADI 72.78
- Support Level
- SNY $47.64
- ADI $234.94
- Resistance Level
- SNY $49.37
- ADI $239.07
- Average True Range (ATR)
- SNY 0.68
- ADI 4.28
- MACD
- SNY 0.14
- ADI 0.76
- Stochastic Oscillator
- SNY 30.56
- ADI 96.08
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About ADI Analog Devices Inc.
Analog Devices is a leading analog, mixed-signal, and digital-signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers; more than half of its chip sales are to industrial and automotive end markets. ADI's chips are also incorporated into wireless infrastructure equipment.